David Harrell serves as Executive at OptimizeRx Corp, where they oversee executive responsibilities. Since joining the company, David Harrell has executed 9 insider transactions totaling $1.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 1, 2017 involved selling 500,000 shares valued at $390.0K.
David Harrell currently holds 2,090,750 shares of OptimizeRx Corp (OPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Harrell has been a net seller of OPRX stock. They have purchased $0 and sold $1.4M worth of shares.
David Harrell's most recent insider trade was on Jun 1, 2017, when they sold 500,000 shares at $0.78 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 1, 2014 | OPRX | $0 | Award | 100,000 | $N/A | Discretionary |
| Apr 24, 2014 | OPRX | $884.0K | Sale | 552,500 | $1.60 | Discretionary |
| Mar 28, 2014 | OPRX | $0 | Award | 60,938 | $N/A | Discretionary |
| Sep 22, 2010 | OPRX | $500.0K | Sale | 400,000 | $1.25 | Discretionary |
| Apr 20, 2010 | OPRX | $0 | Other | 24,000 | $N/A | Discretionary |
| Apr 19, 2010 | OPRX | $0 | Other | 300,000 | $N/A | Discretionary |
| Apr 19, 2010 | OPRX | $0 | Other | 300,000 | $N/A | Discretionary |